(Q53398594)

English

MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study.

scientific article published on 15 August 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

0 references

0 references

1 reference

based on heuristic

inferred from title

magnetic resonance imaging

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Roel A M Heesakkers

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

Anke M Hövels

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

Gerrit J Jager

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

Harrie C M van den Bosch

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

J Alfred Witjes

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

Hein P J Raat

6

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

Johan L Severens

7

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

Eddy M M Adang

8

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

Christina Hulsbergen van der Kaa

9

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

Jurgen J Fütterer

10

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

Jelle Barentsz

11

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

publication date

15 August 2008

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

9

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

9

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

850-856

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

Risk of prostate carcinoma death in patients with lymph node metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Laparoscopic pelvic lymph node dissection allows significantly more accurate staging in “high‐risk” prostate cancer compared to MRI or CT

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Utility of preoperative serumprostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of staging lymphadenectomy in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I clinical evaluation of a new iron oxide MR contrast agent.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymphangiography combined with biopsy and computer tomography to detect lymph node metastases in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sensitivity of computed tomography in evaluation of pelvic lymph node metastases from carcinoma of bladder and prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymph node size does not correlate with the presence of prostate cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Computed tomographic staging of prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnetic resonance imaging of the lymph nodes: comparison with CT

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnetic resonance imaging of abdominal and pelvic lymphadenopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: a new method for noninvasive lymph node evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional lymph node staging using lymphotropic nanoparticle enhanced magnetic resonance imaging with ferumoxtran-10 in patients with penile cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD Initiative.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of lymphadenectomy in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Does the molecular staging in pelvic lymph nodes improve the detection of relevant prostate cancer metastases? An assessment after 6 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970203-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(08)70203-1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/18708295

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53398594&oldid=1521652579"